1. Technical advance: liposomal alendronate depletes monocytes and macrophages in the nonhuman primate model of human disease.
- Author
-
Burwitz BJ, Reed JS, Hammond KB, Ohme MA, Planer SL, Legasse AW, Ericsen AJ, Richter Y, Golomb G, and Sacha JB
- Subjects
- Alendronate administration & dosage, Alendronate toxicity, Animals, Bone Marrow drug effects, Cell Count, Cell Movement drug effects, DNA Replication drug effects, Drug Evaluation, Preclinical, Humans, Injections, Intraperitoneal, Injections, Intravenous, Liposomes, Myeloid Cells cytology, Myeloid Cells drug effects, Alendronate pharmacology, Cell Separation methods, Disease Models, Animal, Flow Cytometry methods, Macaca mulatta immunology, Macrophages drug effects, Monocytes drug effects
- Abstract
Nonhuman primates are critical animal models for the study of human disorders and disease and offer a platform to assess the role of immune cells in pathogenesis via depletion of specific cellular subsets. However, this model is currently hindered by the lack of reagents that safely and specifically ablate myeloid cells of the monocyte/macrophage Lin. Given the central importance of macrophages in homeostasis and host immunity, development of a macrophage-depletion technique in nonhuman primates would open new avenues of research. Here, using LA at i.v. doses as low as 0.1 mg/kg, we show a >50% transient depletion of circulating monocytes and tissue-resident macrophages in RMs by an 11-color flow cytometric analysis. Diminution of monocytes was followed rapidly by emigration of monocytes from the bone marrow, leading to a rebound of monocytes to baseline levels. Importantly, LA was well-tolerated, as no adverse effects or changes in gross organ function were observed during depletion. These results advance the ex vivo study of myeloid cells by flow cytometry and pave the way for in vivo studies of monocyte/macrophage biology in nonhuman primate models of human disease., (© 2014 Society for Leukocyte Biology.)
- Published
- 2014
- Full Text
- View/download PDF